Hepatic Angiosarcoma and Chemoembolization Treatment
Author Information
Author(s): Glenn William Stambo, Michael J. Guiney
Primary Institution: St. Joseph's Hospital and Medical Center
Hypothesis
Can transarterial chemoembolization (TACE) effectively treat hepatic angiosarcoma?
Conclusion
The patient showed significant tumor necrosis and no new enhancing tumors after TACE, although he later died from unrelated causes.
Supporting Evidence
- Hepatic angiosarcoma is a rare and aggressive tumor with a poor prognosis.
- The patient presented with acute intraperitoneal hemorrhage due to tumor rupture.
- TACE was performed successfully with no immediate complications.
Takeaway
A man with a rare liver cancer was treated with a special procedure that helped shrink his tumor, but he unfortunately passed away later from heart issues.
Methodology
The patient underwent transarterial chemoembolization (TACE) using a combination of embolic agents and chemotherapy drugs.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
54-year-old male with a history of hemachromatosis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website